As combination treatment of vemurafenib and C012 increases TRIM16 protein expression, we investigated the tumor growth rate of engrafted BRAFWT/NRASQ61R melanoma cells, sensitive to the drug combination in vitro, in a xenograft model. The gene discussed is TRIM16; the disease is melanoma.